GMP Compliance

Quality Management Systems

Good Manufacturing Practice

FDA Warning Letters Jumped 50% in FY2025. Is Your Supplier Quality System Ready for the Next Inspection?

GMP compliance demands continuous audit readiness across every supplier, site, and certificate in your manufacturing network—with FDA, EMA, and PIC/S inspectors scrutinizing data integrity, CAPA effectiveness, and supplier oversight at every audit. The QMSR transition is now in effect. EU GMP Annex revisions continue through 2028. Certivo automates GMP supplier qualification from certificate collection to inspection-ready documentation.

4,800+ Drug manufacturing sites in FDA's CDER Site Catalog worldwide

57 PIC/S Participating Authorities enforcing harmonized GMP standards

85 FDA warning letters to drug manufacturers in 2025 alone

Regulation Overview

Jurisdiction: Global (FDA, EMA, WHO, PIC/S, and national regulatory authorities)

Regulatory Body: FDA (US), EMA (EU), WHO, PIC/S (57 participating authorities)

Regulation Number: 21 CFR Parts 210/211 (drugs), 21 CFR Part 820 / QMSR (devices), EU GMP Volume 4, ICH Q7–Q14

Effective Date: FDA cGMP codified 1978; EU GMP Directive 2003/94/EC; QMSR effective February 2, 2026

Official Source: FDA.gov, EMA.europa.eu, PICScheme.org, ICH.org

Key Threshold: ISO 13485:2016 (incorporated by reference into QMSR)

What is GMP?

Good Manufacturing Practice is the global baseline for pharmaceutical, biotechnology, and medical device manufacturing quality. For supply chain and compliance teams, GMP compliance centers on maintaining validated processes, controlled documentation, qualified suppliers, and continuous audit readiness across every manufacturing site and supplier in the network.

GMP requirements are enforced by over 57 national regulatory authorities through PIC/S harmonization. FDA's CDER alone monitors over 4,800 drug manufacturing sites worldwide, and CDER warning letters rose 50% in FY2025—with 35% citing GMP manufacturing failures and 15% flagging data integrity violations. Companies manufacturing or sourcing regulated products must demonstrate pharmaceutical quality management through validated processes, traceable records, qualified personnel, and rigorous supplier oversight.

Key Components / Sub-Frameworks

Obligation: Process validation, lab controls, documentation, personnel qualification
21 CFR Parts 210/211: FDA cGMP for drug products
Obligation: ISO 13485 compliance, design controls, CAPA, supplier controls
QMSR (21 CFR Part 820): FDA quality system for medical devices (effective Feb 2, 2026)
Obligation: Pharmaceutical quality system, contamination control, data integrity
EU GMP (EudraLex Vol. 4): European GMP guidelines and annexes
Obligation: API manufacturing, process controls, supplier qualification
ICH Q7: GMP for active pharmaceutical ingredients
Obligation: Lifecycle quality management, knowledge management, continual improvement
ICH Q10: Pharmaceutical quality system
Obligation: Aligned with EU GMP; covers 57 regulatory authorities globally
PIC/S GMP Guide: Harmonized international GMP standards

FDA's QMSR Took Effect February 2, 2026—ISO 13485 Is Now a Regulatory Requirement for All US Medical Device Manufacturers. Have You Updated Your Supplier Quality Agreements?

The QMSR replaces the legacy QSR and incorporates ISO 13485:2016 by reference. FDA has retired the QSIT inspection technique and adopted a new inspection program (7382.850). Simultaneously, the EMA's 2026–2028 work plan targets revisions to EU GMP Annex 15 (qualification and validation) and Annex 6 (medicinal gases), with public consultations running through April 2026. In April 2026, FDA issued its first warning letter citing AI misuse in pharmaceutical manufacturing. Supplier quality agreements and GMP documentation from last year may no longer be compliant.

Key Compliance Requirements

Who Must Comply

• Pharmaceutical manufacturers of drug substances and drug products
• Medical device manufacturers placing products on US or EU markets
• Biotechnology companies producing biologics and ATMPs
• Contract manufacturing organizations (CMOs) and CDMOs
• API manufacturers and suppliers in regulated supply chains
• Importers and distributors of GMP-regulated products

Key Thresholds

21 CFR 211

Applies to all finished pharmaceutical drug products distributed in the US

ISO 13485:2016

Now incorporated into QMSR; mandatory for all US medical device manufacturers

EU GMP Annex 1

Fully effective since August 2024; applies to all sterile product manufacturers

15 business days

FDA response deadline after receiving Form 483 observations

Core Obligations

1. Process Validation Validate all manufacturing processes with documented evidence of consistent output DEADLINE Prior to commercial distribution

2. Supplier Qualification Qualify and audit all suppliers of critical materials, APIs, and components DEADLINE Ongoing; risk-based frequency

3. CAPA Management Investigate deviations, identify root causes, implement corrective and preventive actions DEADLINE Per event; tracked to closure

4. Documentation & Data Integrity Maintain complete, accurate, attributable, contemporaneous records (ALCOA+ principles) DEADLINE Continuous

5. Change Control Document, assess, and approve all changes to processes, materials, and equipment DEADLINE Prior to implementation

GMP-Specific Pain Points

The Multi-Authority Compliance Maze

Your products ship to 12 markets, each with a different GMP authority. FDA expects 21 CFR 211 compliance. The EMA requires EU GMP Annex 1 adherence. PIC/S harmonizes some requirements but not all. Your team maintains separate documentation sets for each jurisdiction, manually cross-referencing audit findings against different regulatory expectations—while regulatory intelligence updates arrive faster than your team can process them.

The 15-Day Response Clock

An FDA inspector issues a Form 483 with six observations. Your quality unit has 15 business days to respond with a credible corrective action plan. But the evidence—supplier certificates, validation records, CAPA documentation—is scattered across shared drives, email attachments, and paper files. Day 14: your response references documents you cannot locate. Day 16: the inspector escalates to a warning letter recommendation.

The Supplier Qualification Gap

Your supply chain spans 200 suppliers across three tiers. FDA warning letter trends show that supplier oversight failures are among the most frequently cited GMP violations. But your supplier qualification files are 18 months old. Certificates have expired. Audit reports reference processes that have since changed. Without a centralized compliance data backbone, you cannot demonstrate current supplier qualification status to an inspector.

The Data Integrity Burden

Data integrity violations appeared in 15% of all 2025 FDA warning letters—with Indian manufacturing sites cited at a 60% rate for data integrity issues. Inspectors look for ALCOA+ compliance across every batch record, lab notebook, and electronic system. Manual, paper-based, or hybrid systems cannot provide the immutable audit trails, access controls, and contemporaneous recording that regulators now demand at scale.

Certivo in Action

Certivo in Action—GMP Workflow

GET EVIDENCE IN

Collect GMP Certificates, Audit Reports, and Supplier Qualifications—Without the Chasing

CORA launches targeted campaigns to collect GMP supplier qualification documents, follows up automatically, and accepts responses in any format.

• Launch GMP qualification campaigns to hundreds of suppliers with one click
• CORA-powered outreach in suppliers' native languages
• Accept any format: GMP certificates, ISO 13485 certificates, audit reports, COAs, PDFs
• Track response rates and escalate non-responders automatically

MAKE SENSE OF IT

Know Instantly When Supplier Certificates Expire or Audit Findings Require Action

CORA extracts certificate details, validates against current GMP requirements, and flags gaps in supplier qualification status automatically.

• CORA parses certificates to extract issuing authority, scope, expiration dates, and audit findings
• Automatic validation against FDA, EMA, PIC/S, and ISO 13485 requirements
• Real-time alerts when certificates approach expiration or regulations update
• BOM-level compliance intelligence linking supplier qualification to product impact

PROVE COMPLIANCE OUT

Respond to Inspector Requests in Hours, Not Weeks

Generate audit-ready documentation packages instantly from validated supplier data and qualification records.

• One-click inspection-readiness packages with full supplier qualification evidence
• Pre-formatted documentation meeting FDA, EMA, and PIC/S expectations
• Customer-specific compliance packages with full traceability
• Complete audit trail for every validation, certificate, and supplier interaction

One Supplier Submission. Validation Against FDA, EMA, and PIC/S Requirements. Audit-Ready in Hours.

Certivo reads supplier documents, extracts certificate and qualification data with AI document parsing and certificate validation, validates against global GMP requirements, and generates inspection-ready evidence automatically. When regulations update—QMSR, EU GMP Annex revisions, ICH guideline implementations—Certivo reassesses your supplier network and alerts you before inspectors arrive.

Features Tabs

Declaration Collection

Certivo's automated supplier data collection campaigns achieve 95% response rates vs. 20–30% with manual outreach.

• Targeted campaigns by product line, supplier tier, or qualification category
• Multi-language outreach in suppliers' native languages
• Intelligent follow-up sequences adapting to supplier behavior
• Format-agnostic: GMP certificates, ISO 13485 certificates, audit reports, COAs, freeform responses

AI Extraction

Every certificate and qualification document parsed automatically—no manual data entry.

• Deep extraction of issuing authority, scope, expiration dates, audit findings, and corrective actions
• Parses GMP certificates, ISO 13485 certificates, COAs, audit reports, and proprietary formats
• Multi-language document processing across global supply chains
• Anomaly detection for expired, inconsistent, or suspicious supplier documentation

GMP Monitoring

Always validated against current GMP requirements—not your last audit cycle.

• Automatic sync with FDA, EMA, PIC/S, and ICH regulatory updates
• Supplier risk scoring and due diligence based on certificate status, audit history, and regulatory changes
• Proactive alerts when regulatory updates affect your supplier network
• Historical tracking of supplier qualification status changes and CAPA closures

Reporting & Audit Readiness

Generate complete audit documentation in hours instead of 4–6 weeks.

• One-click inspection packages with full supplier qualification evidence and certificate chains
• Documentation templates meeting FDA Form 483 response expectations
• Supplier qualification summaries with complete traceability across multi-tier supply chains
• Continuous compliance monitoring and audit readiness dashboards with real-time status

Integrated Compliance Thread

One supplier submission validates against GMP, ISO 13485, EU MDR, and related quality frameworks simultaneously.

• Pre-mapped compliance requirements across FDA cGMP, EU GMP, PIC/S, and ISO 13485
• Integrated PLM ERP compliance thread connecting supplier qualification to product records
• Centralized supplier self-service portals for ongoing document submissions
• Digital passport and traceability systems linking certificates to BOM-level product data

Related Regulations

EU MDR / IVDR

Medical device regulations requiring QMS and supplier controls

ISO 13485:2016

International QMS standard now incorporated into FDA QMSR

REACH

Chemical substance compliance intersects material qualification

EU RoHS

Hazardous substance restrictions apply to device materials

ICH Q7–Q14

Harmonized pharmaceutical quality guidelines

Industries Most Impacted

Pharmaceuticals & Biotech

Your Pain Point: Multi-site validation; API supplier oversight; data integrity across global CMO network

Medical Devices & Equipment

Your Pain Point: QMSR transition to ISO 13485; EU MDR supplier controls; design traceability

Chemical Manufacturing

Your Pain Point: ICH Q7 API requirements; supplier qualification across multi-tier raw material chains

Electronics Manufacturing

Your Pain Point: Component-level material traceability; converging quality and substance requirements

Automotive Manufacturing

Your Pain Point: IATF 16949 intersects with GMP for medical automotive components; global supplier base

Consumer Goods

Your Pain Point: High SKU counts; frequent supplier changes; FDA OTC drug GMP requirements

Aerospace & Defense

Your Pain Point: AS9100 quality intersects GMP for defense pharma; stringent audit requirements

Industrial Machinery & Heavy Equipment

Your Pain Point: Cleanroom equipment GMP requirements; supplier qualification for critical components

Return on Investment

80% Reduction in Compliance Labor: From Manual Assembly to Exception Management CORA extracts supplier qualification data automatically through AI document parsing and certificate validation. Your team focuses on exceptions that need human judgment—not manual certificate tracking and document assembly.

4 Hours To Inspection-Ready Package: Audit Readiness Acceleration Generate complete, validated inspection documentation packages in hours—not the 4–6 weeks of manual compilation across scattered systems and email archives.

Real-Time Regulatory Intelligence Sync: Proactive GMP Compliance Monitoring When FDA, EMA, PIC/S, or ICH guidelines update, Certivo reassesses your supplier network instantly through regulatory intelligence and horizon scanning. Know which suppliers and products are affected before inspectors arrive.

Key Statistics

57 PIC/S authorities tracked with automatic regulatory sync

99.2% Certificate extraction accuracy from supplier documents

95% Supplier response rate with CORA-powered campaigns

Frequently Asked Questions

What products and companies are subject to GMP compliance requirements?
Any company manufacturing, processing, or distributing pharmaceutical drug products, medical devices, biologics, or active pharmaceutical ingredients for regulated markets must comply with applicable GMP requirements. This includes contract manufacturers, API suppliers, importers, and distributors. In the US, FDA enforces 21 CFR Parts 210/211 for drugs and the new QMSR (incorporating ISO 13485) for devices. The EU enforces EudraLex Volume 4, and 57 PIC/S participating authorities enforce harmonized GMP standards globally.

What are the penalties for GMP non-compliance?
FDA enforcement actions escalate from Form 483 observations to warning letters, consent decrees, import alerts, product seizures, injunctions, and criminal prosecution. CDER issued 85 warning letters to drug manufacturers in 2025—a 50% increase over FY2024. Warning letters are publicly accessible, creating reputational risk visible to customers, partners, and investors. In the EU, national authorities can suspend manufacturing authorizations and withdraw products from market. CORA helps organizations maintain continuous compliance monitoring to avoid these outcomes.

How does Certivo track updates to GMP regulations across multiple authorities?
Certivo maintains continuous sync with FDA, EMA, PIC/S, ICH, and national regulatory authority updates through built-in regulatory intelligence and horizon scanning. When requirements change—such as the QMSR transition, EU GMP Annex revisions, or new ICH guideline implementations—CORA reassesses your supplier network and alerts you to affected qualifications, triggering appropriate re-qualification and documentation workflows automatically.

What supplier document formats does Certivo accept for GMP qualification?
Certivo accepts any format: GMP certificates, ISO 13485 certificates, certificates of analysis, audit reports, CAPA documentation, quality agreements, PDFs, Excel files, and freeform responses. CORA extracts qualification data regardless of format or language through AI document parsing and certificate validation, eliminating the need to standardize supplier inputs across your global supply chain.

Does Certivo support both FDA and EU GMP requirements alongside related quality frameworks?
Yes. Certivo validates against FDA cGMP (21 CFR 210/211), QMSR (ISO 13485), EU GMP (EudraLex Volume 4), PIC/S harmonized standards, and ICH quality guidelines simultaneously. The same supplier submission is also validated against related substance frameworks—REACH, RoHS, TSCA—eliminating duplicate collection campaigns and providing a centralized compliance data backbone across quality and substance requirements.

Ready to Automate GMP Compliance?

See how Certivo's pharmaceutical quality management software transforms GMP supplier qualification from reactive firefighting to continuous audit readiness.